Article Data

  • Views 511
  • Dowloads 123

Original Research

Open Access

Borderline ovarian tumors: outcomes of fertility sparing surgery

  • S.S. Ozalp1,
  • O.T. Yalcin1
  • E. Telli1,*,
  • T. Oge1
  • S. Kabukcuoglu1

1Eskisehir Osmangazi University School of Medicine, Eskisehir (Turkey)

DOI: 10.12892/ejgo24062014 Vol.35,Issue 2,March 2014 pp.154-156

Published: 10 March 2014

*Corresponding Author(s): E. Telli E-mail: drelcinuzmez@hotmail.com

Abstract

Aim: Borderline ovarian tumors(BOT) account for ten to 20 percent of all epitelial ovarian carcinomas and often occur in reproductive ages. The aim of this study was to evaluate the clinical and reproductive outcomes of patients who were diagnosed with BOT and underwent fertility sparing surgery. Materials and Methods: Patients younger than 40 years who underwent fertility sparing surgery for BOT from 2004 to 2012 were reviewed retrospectively and were evaluated according to the reproductive and clinical outcomes. Results: Twenty-eight patients younger than 40 years with BOT underwent fertility sparing surgery. Median follow up time was 42 ± 28.1 months. During the follow up period, two patients (7.1%) developed recurrence at 35 and 36 months, respectively. Five (17.9%) out of 28 patients became pregnant during the follow up period. Conclusion: Fertility sparing surgery should be the first choice for the treatment of BOT in patients who wish to preserve fertility.

Keywords

Borderline ovarian tumors; Fertility sparing surgery; Pregnancy.

Cite and Share

S.S. Ozalp,O.T. Yalcin,E. Telli,T. Oge,S. Kabukcuoglu. Borderline ovarian tumors: outcomes of fertility sparing surgery. European Journal of Gynaecological Oncology. 2014. 35(2);154-156.

References

[1] Sherman M.E., Mink P.J., Curtis R., Cote T.R., Brooks S., Hartge P., Devesa S.: “Survival among women with borderline ovarian tumors and ovarian carcinoma:a population-based analysis”. Cancer, 2004, 100, 1045.

[2] Park J.Y., Kim D.Y., Kim J.H., Kim Y.M., Kim Y.T., Nam J.H.: “Surgical management of borderline ovarian tumors:The role of fertility-sparing surgery”. Gynecol. Oncol., 2009, 113, 75.

[3] Song T., Choi C.H., Park H.S., Kim M.K., Lee Y.Y., Kim T.J. et al.: “Fertility-sparing surgery for borderline ovarian tumors: oncologic safety and reproductive outcomes”. Int. J. Gynecol. Cancer, 2011, 21, 640.

[4] Fain-Kahn V., Poirot C., Uzan C., Prades M., Gouy S., Genestie C. et al.: “Feasibility of ovarian cryopreservation in borderline ovarian tumours”. Hum. Reprod., 2009, 24, 850.

[5] Viganò R., Petrone M., Pella F., Rabaiotti E., De Marzi P., Mangili G.: “Surgery in advanced borderline tumors”. Fertil. Steril., 2010, 94, 1163.

[6] Romeo M., Pons F., Barretina P., Radua J.: “Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor”. World J. Surg. Oncol., 2013, 11, 13.

[7] Morice P.: “Borderline tumours of the ovary and fertility”. Eur. J. Cancer, 2006, 42, 149.

[8] Romagnolo C., Gadducci A., Sartori E., Zola P., Maggino T.: “Management of borderline ovarian tumors: results of an Italian multi-center study”. Gynecol. Oncol., 2006, 101, 255.

[9] Poncelet C., Fauvet R., Boccara J., Daraï E.: “Recurrence after cystectomy for borderline ovarian tumors: results of a French multi-center study”. Ann. Surg. Oncol., 2006, 13, 565.

[10] Ren J., Lou J.Y., Liu H., Wang P., Zhang J.W., Yang K.X. et al.: “Clinicopathologic features of 234 cases with borderline ovarian tu-mors”. Zhonghua Fu Chan Ke Za Zhi, 2009, 44, 116.

[11] Ewald-Riegler N., du Bois O., Fisseler-Eckhoff A., Kommoss F., Harter P., Traut A. et al.: “Borderline tumors of the ovary: clinical course and prognostic factors”. Onkologie, 2012, 35, 28.

[12] Fauvet R., Brzakowski M., Morice P., Resch B., Marret H., Graesslin O.: “Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter study”. Ann. Oncol., 2012, 23, 1481.

[13] Suh-Burgmann E.: “Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study”. Gynecol. Oncol., 2006, 103, 841.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top